Locust Walk Acquisition (LWAC) Stock Price, News & Analysis

Company Overview

Locust Walk Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Boston, Massachusetts.

Key Stats

• Today's Range: N/A
• 50-Day Range: $8.76 to $16.98
• 52-Week Range: N/A
• Volume: 7.84 million shs
• Average Volume: 168,660 shs
• Market Capitalization: $373.75 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LWAC Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Locust Walk Acquisition own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Locust Walk Acquisition investors own include Shell (SHEL), Virpax Pharmaceuticals (VRPX), Sonnet BioTherapeutics (SONN), NanoVibronix (NAOV) and

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: Pharmaceutical Preparations
• Sub-Industry: N/A
• Current Symbol: NASDAQ:LWAC
• CIK: N/A
• Web: www.locustwalkacquisitioncorp.com
• Phone: 415-697-0763
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.68
• Quick Ratio: 0.68

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: 20,911.52
• Book Value: $0.23 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 22,011,000
• Free Float: N/A
• Market Cap: $373.75 million
• Optionable: Not Optionable
• Beta: N/A